KRAS and pancreatic neoplasm: Additionally, the increased plasma levels of leucine, isoleucine, and valine are connected to a risk of pancreatic cancer in the future that is more than twice as high and are also characteristic of early-stage pancreatic cancers driven by mutant Kras expression [180].